SERAFINI MARTA

Faraguna, M., Crescitelli, V., Bonanomi, S., Kullmann, G., Boffi, M., Pretese, R., et al. (2026). A comprehensive study on the effect of alglucosidase alpha and immunomodulation on survival, motor and cardiac outcome, creatine kinase and antibody titers in classic infantile Pompe disease: the Monza experience. CURRENT OPINION IN IMMUNOLOGY, 99(April 2026) [10.1016/j.coi.2026.102725]. Detail

Palmisano, B., Tavanti, C., Farinacci, G., Corsi, A., Serafini, M., Appelman-Dijkstra, N., et al. (2026). Effects of anti-RANKL, Zoledronate or combination therapy in a mouse model of fibrous dysplasia: a preclinical study. JOURNAL OF BONE AND MINERAL RESEARCH, 1-16 [10.1093/jbmr/zjag037]. Detail

Pisani, I., Melita, G., de Souza, P., Galimberti, S., Savino, A., Sarno, J., et al. (2025). Optimized GMP-grade production of non-viral Sleeping Beauty-generated CARCIK cells for enhanced fitness and clinical scalability. JOURNAL OF TRANSLATIONAL MEDICINE, 23(1) [10.1186/s12967-025-06416-3]. Detail

De Ponti, G., Santi, L., Dina, G., Pievani, A., Donsante, S., Riminucci, M., et al. (2025). Neonatal gene therapy effectively prevents disease manifestations in a murine model of Mucopolysaccharidosis type I. MOLECULAR THERAPY. METHODS & CLINICAL DEVELOPMENT, 33(3 (11 September 2025)) [10.1016/j.omtm.2025.101544]. Detail

Lisi-Vega, L., Pievani, A., García-Fernández, M., Forte, D., Williams, T., Serafini, M., et al. (2025). Bone marrow mesenchymal stromal cells support translation in refractory acute myeloid leukemia. CELL REPORTS, 44(1) [10.1016/j.celrep.2024.115151]. Detail